NEXNY Stock Research

Today

Replimune announces FDA accelerated approval of Tudriqev for advanced melanoma

REPL

5:46 PM

CytomX Therapeutics reports Q2 EPS (9c), consensus (10c)

CTMX

5:44 PM

Cognition Therapeutics reports Q2 EPS (4c), consensus (6c)

CGTX

5:41 PM

Alta narrows FY26 adjusted EBITDA view to $167.5M-$177.5M from $167.5M-$182.5M

ALTG

5:41 PM

Goldman Sachs BDC reports Q2 adjusted NII 37c, consensus 31c

GSBD

5:41 PM

Alta Equipment reports Q2 EPS (4c), consensus (11c)

ALTG

5:40 PM

X4 Pharmaceuticals reports Q2 EPS (13c), consensus (18c)

XFOR

5:39 PM

US Foods price target raised by $3 at TD Cowen, here's why

USFD

5:37 PM

Nephros reports Q2 EPS 11c, consensus 0c

NEPH

5:37 PM

Zymeworks reports Q2 EPS (62c), consensus (55c)

ZYME

5:36 PM

Solid Biosciences reports Q2 EPS (38c), consensus (47c)

SLDB

5:36 PM

Ready Capital reports Q2 distributable EPS (47c), consensus (48c)

5:35 PM

El Pollo Loco raises FY26 adjusted EBITDA view to $68M-$70M from $67.5M-$69.5M

LOCO

5:34 PM

BCP Investment reports Q2 NII 45c, consensus 41c

BCIC

5:33 PM

Relmada Therapeutics reports Q2 EPS (11c), consensus (20c)

RLMD

5:33 PM

El Pollo Loco reports Q2 EPS 30c, consensus 28c

LOCO

5:32 PM

Serve Robotics cuts FY26 revenue view to $9M-$10M from $26M

SERV

5:32 PM

Serve Robotics reports Q2 EPS (80c) vs (65c) last year

SERV

5:31 PM

Aclaris Therapeutics receives FDA Fast Track Designation for Modzatinib

ACRS

5:30 PM

Red Cat backs FY26 revenue view $150M-$180M, consensus $155.05M

RCAT

5:29 PM

Fidus Investment declares 7c per share supplemental dividend

FDUS

5:28 PM

Red Cat reports Q2 EPS (26c), consensus (17c)

RCAT

5:28 PM

Mercer reports Q2 EPS ($1.13), two estimates ($1.04)

MERC

5:27 PM

Artiva Biotherapeutics files $400M mixed securities shelf

ARTV

5:27 PM

Dropbox raises FY26 GAPP revenue view to $2.513B-$2.523B from $2.5B-$2.51B

5:27 PM

Charts

Today

Replimune announces FDA accelerated approval of Tudriqev for advanced melanoma

REPL

5:46 PM

CytomX Therapeutics reports Q2 EPS (9c), consensus (10c)

CTMX

5:44 PM

Cognition Therapeutics reports Q2 EPS (4c), consensus (6c)

CGTX

5:41 PM

Alta narrows FY26 adjusted EBITDA view to $167.5M-$177.5M from $167.5M-$182.5M

ALTG

5:41 PM

Goldman Sachs BDC reports Q2 adjusted NII 37c, consensus 31c

GSBD

5:41 PM

Alta Equipment reports Q2 EPS (4c), consensus (11c)

ALTG

5:40 PM

X4 Pharmaceuticals reports Q2 EPS (13c), consensus (18c)

XFOR

5:39 PM

US Foods price target raised by $3 at TD Cowen, here's why

USFD

5:37 PM

Nephros reports Q2 EPS 11c, consensus 0c

NEPH

5:37 PM

Zymeworks reports Q2 EPS (62c), consensus (55c)

ZYME

5:36 PM

Solid Biosciences reports Q2 EPS (38c), consensus (47c)

SLDB

5:36 PM

Ready Capital reports Q2 distributable EPS (47c), consensus (48c)

5:35 PM

El Pollo Loco raises FY26 adjusted EBITDA view to $68M-$70M from $67.5M-$69.5M

LOCO

5:34 PM

BCP Investment reports Q2 NII 45c, consensus 41c

BCIC

5:33 PM

Relmada Therapeutics reports Q2 EPS (11c), consensus (20c)

RLMD

5:33 PM

El Pollo Loco reports Q2 EPS 30c, consensus 28c

LOCO

5:32 PM

Serve Robotics cuts FY26 revenue view to $9M-$10M from $26M

SERV

5:32 PM

Serve Robotics reports Q2 EPS (80c) vs (65c) last year

SERV

5:31 PM

Aclaris Therapeutics receives FDA Fast Track Designation for Modzatinib

ACRS

5:30 PM

Red Cat backs FY26 revenue view $150M-$180M, consensus $155.05M

RCAT

5:29 PM

Fidus Investment declares 7c per share supplemental dividend

FDUS

5:28 PM

Red Cat reports Q2 EPS (26c), consensus (17c)

RCAT

5:28 PM

Mercer reports Q2 EPS ($1.13), two estimates ($1.04)

MERC

5:27 PM

Artiva Biotherapeutics files $400M mixed securities shelf

ARTV

5:27 PM

Dropbox raises FY26 GAPP revenue view to $2.513B-$2.523B from $2.5B-$2.51B

5:27 PM

Company News

Charts

Company News

Charts